| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3199121 | Journal of Allergy and Clinical Immunology | 2012 | 6 Pages |
Abstract
In combination with fexofenadine, single doses of PF-03654746 caused a reduction in allergen-induced nasal symptoms. H3 receptor antagonism might be a novel therapeutic strategy to further explore in patients with allergic rhinitis.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Jeffrey R. MD, Francisco A. MS, Richard J. BSc, Peter G. MD, Frances BSc, Janie MA, Thomas B. MD,